Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from NIH: NSAID-related gene with antitumorigenic properties

Feb. 15, 2001

Ilex Oncology acquires Symphar; Symphar becomes Ilex Research-Europe

Feb. 14, 2001

Genta's Genasense enters phase III evaluation for multiple myeloma

Feb. 14, 2001

Discovery of prostate cancer gene detailed by Myriad

Feb. 14, 2001

Licensing opportunity from NIH: BRCA1 mutants for modulating cellular response to DNA damage

Feb. 14, 2001

Antiangiogenic tyrosine kinase inhibitors disclosed by Celltech scientists in recent patent

Feb. 13, 2001

Increased survival results with Aphton's antigastrin vaccine reported

Feb. 13, 2001

TSP-1 antiangiogenic gene therapy and its application in prostate cancer

Feb. 13, 2001

Licensing opportunity from NIH: viral chemokine-antigen fusion proteins

Feb. 13, 2001

Licensing opportunity from NIH: defensin-tumor antigen fusions

Feb. 13, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...